05/26/2026
What scares me about GLP-1s in type 1 diabetes isn't the medication. It's starting without a plan.
In the ADJUST-T1D trial, total daily insulin dropped 18% by week 4 β at the lowest starting dose of 0.25 mg. Bolus insulin dropped 23%. And 83% of that reduction was a direct drug effect, not weight loss.
The drop comes before the scale moves.
You don't wait to adjust. You adjust at initiation β proactively reducing bolus settings by 20β30%.The trials give us this roadmap.
This week I'm walking through what they found.
Save this series if you or someone you love has type 1 diabetes.π